CVS Health Co. (NYSE:CVS) Shares Sold by Todd Asset Management LLC

Todd Asset Management LLC lowered its position in CVS Health Co. (NYSE:CVS) by 1.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 226,804 shares of the pharmacy operator’s stock after selling 3,045 shares during the quarter. Todd Asset Management LLC’s holdings in CVS Health were worth $17,908,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the business. Atticus Wealth Management LLC raised its stake in CVS Health by 149.0% during the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 219 shares in the last quarter. Cornerstone Planning Group LLC lifted its holdings in CVS Health by 111.5% in the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 243 shares during the period. ZRC Wealth Management LLC grew its position in CVS Health by 400.0% in the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock valued at $39,000 after buying an additional 400 shares in the last quarter. Coston McIsaac & Partners increased its stake in CVS Health by 42.6% during the 4th quarter. Coston McIsaac & Partners now owns 539 shares of the pharmacy operator’s stock valued at $42,000 after buying an additional 161 shares during the period. Finally, Tennessee Valley Asset Management Partners acquired a new stake in shares of CVS Health in the 4th quarter worth approximately $50,000. Institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on CVS shares. Leerink Partnrs downgraded CVS Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday. Mizuho decreased their price target on shares of CVS Health from $86.00 to $72.00 and set a “buy” rating on the stock in a research report on Thursday. Royal Bank of Canada decreased their target price on CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a report on Thursday, February 8th. The Goldman Sachs Group decreased their price target on CVS Health from $85.00 to $74.00 and set a “buy” rating for the company in a research report on Thursday. Finally, Wells Fargo & Company reduced their price objective on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating for the company in a research note on Monday, April 8th. Eight analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $80.35.

Insider Buying and Selling

In related news, Director Edward J. Ludwig purchased 1,000 shares of the firm’s stock in a transaction on Thursday, May 2nd. The shares were bought at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the transaction, the director now directly owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, Director Edward J. Ludwig bought 1,000 shares of CVS Health stock in a transaction that occurred on Thursday, May 2nd. The stock was acquired at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the purchase, the director now owns 21,630 shares in the company, valued at $1,165,424.40. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the transaction, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at approximately $3,059,916.75. The disclosure for this sale can be found here. 0.24% of the stock is currently owned by insiders.

CVS Health Stock Up 1.4 %

NYSE:CVS traded up $0.75 during mid-day trading on Friday, reaching $55.90. The stock had a trading volume of 23,946,075 shares, compared to its average volume of 12,498,538. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.63. CVS Health Co. has a fifty-two week low of $53.70 and a fifty-two week high of $83.25. The business’s 50 day moving average is $72.77 and its 200 day moving average is $73.26. The stock has a market cap of $70.18 billion, a P/E ratio of 9.82, a PEG ratio of 0.86 and a beta of 0.56.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The firm had revenue of $88.44 billion during the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. CVS Health’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.20 earnings per share. As a group, sell-side analysts predict that CVS Health Co. will post 7.03 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd were given a $0.665 dividend. The ex-dividend date of this dividend was Friday, April 19th. This represents a $2.66 annualized dividend and a dividend yield of 4.76%. CVS Health’s dividend payout ratio is 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.